AMT Holding « Terug naar discussie overzicht

Amsterdam Molecular Therapeutics Publishes Positive Data from Glybera® 14 Week Study

Er zijn (nog) geen reacties geplaatst.

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

 AEX
922,75  +8,78  +0,96%  18:05
 Germany40^ 23.275,40 -0,45%
 BEL 20 4.499,43 -0,01%
 Europe50^ 5.504,20 +0,35%
 US30^ 41.804,30 +0,55%
 Nasd100^ 19.695,00 +1,06%
 US500^ 5.659,67 +0,77%
 Japan225^ 37.839,20 +0,15%
 Gold spot 3.039,31 +0,16%
 EUR/USD 1,0888 -0,49%
 WTI 66,90 +0,56%
#/^ Index indications calculated real time, zie disclaimer

Stijgers

CM.COM +6,95%
Accsys +2,80%
ASMI +2,60%
JDE PEET'S +2,42%
Alfen N.V. +2,24%

Dalers

Sif Holding -14,69%
Avantium -5,78%
NX FILTRATION -3,87%
B&S Group SA -2,78%
RANDSTAD NV -2,24%

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront